| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326686 | Gynecologic Oncology | 2005 | 7 Pages |
Abstract
Increased EpoR expression in ovarian LMP tumors and carcinoma is demonstrated by Western blot analysis and IHC staining. Furthermore, adversely effects sensitivity to cisplatin in the ovarian cancer cell lines. These data add to the growing body of evidence suggesting possible detrimental effects of erythropoietin.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
John W. McBroom, Geza Acs, G. Scott Rose, Thomas C. Krivak, Ahmed Mohyeldin, Aaron Bell, Ajay Verma,